Sjoerd de Hoogd
Overview
Explore the profile of Sjoerd de Hoogd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Hoogd S, Goulooze S, Valkenburg A, Krekels E, Dijk M, Tibboel D, et al.
Pediatr Res
. 2021 Feb;
90(6):1201-1206.
PMID: 33603216
Background: Morphine is commonly used for postoperative analgesia in children. Here we studied the pharmacodynamics of morphine in children after cardiac surgery receiving protocolized morphine. Methods: Data on morphine rescue...
2.
Matic M, de Hoogd S, de Wildt S, Tibboel D, Knibbe C, van Schaik R
Pharmacogenomics
. 2020 Jan;
21(3):181-193.
PMID: 31967515
Investigate the potential role of (mu-opioid receptor) and (catechol-O-methyltransferase enzyme) polymorphisms in postoperative acute, chronic and experimental thermal pain. A secondary analysis of 125 adult cardiac surgery patients that were...
3.
de Hoogd S, Wong D, de Vries D, Harmsze A
Eur J Gastroenterol Hepatol
. 2019 Aug;
31(12):1592-1596.
PMID: 31464791
Azathioprine and mercaptopurine are widely used in the treatment of inflammatory bowel disease. However, its use is limited by adverse drug event related to the relatively narrow therapeutic index of...
4.
de Hoogd S, Valkenburg A, van Dongen E, Daeter E, van Rosmalen J, Dahan A, et al.
Eur J Anaesthesiol
. 2018 Sep;
36(1):32-39.
PMID: 30211725
Background: The clinical relevance of the suggested hyperalgesic effects of remifentanil is still unclear, especially in the long term. Objective: The current study evaluated the impact of remifentanil on thermal...
5.
Smit C, de Hoogd S, Bruggemann R, Knibbe C
Expert Opin Drug Metab Toxicol
. 2018 Feb;
14(3):275-285.
PMID: 29431542
The rising prevalence of obesity confronts clinicians with dosing problems in the (extreme) overweight population. Obesity has a great impact on key organs that play a role in the pharmacokinetics...
6.
de Hoogd S, Ahlers S, van Dongen E, van de Garde E, Daeter E, Dahan A, et al.
Pain Pract
. 2017 Jul;
18(4):443-451.
PMID: 28741894
Background: Remifentanil has been associated with increased acute and potentially chronic postoperative pain. The objective of this prospective randomized controlled trial was to investigate the influence of intraoperative remifentanil on...
7.
de Hoogd S, Valitalo P, Dahan A, van Kralingen S, Coughtrie M, van Dongen E, et al.
Clin Pharmacokinet
. 2017 May;
56(12):1577-1587.
PMID: 28510797
Introduction: Obesity is associated with many pathophysiological changes that may result in altered drug metabolism. The aim of this study is to investigate the influence of obesity on the pharmacokinetics...
8.
de Hoogd S, Ahlers S, van Dongen E, van de Garde E, Hamilton-Ter Brake T, Dahan A, et al.
Clin J Pain
. 2015 Dec;
32(8):726-35.
PMID: 26626296
Objective: Remifentanil is an ultra-short-acting opioid that is used commonly during both short-term and prolonged surgery. This review investigated associations of intraoperative remifentanil administration with acute postoperative pain, hyperalgesia, and...
9.
de Hoogd S, Ahlers S, van Dongen E, Tibboel D, Dahan A, Knibbe C
Trials
. 2014 Nov;
15:466.
PMID: 25429720
Background: Chronic thoracic pain after cardiac surgery is prevalent (11 to 56%) and may affect patients' physical and mental health status. Despite its favorable pharmacokinetic and pharmacodynamic properties, high doses...
10.
de Hoogd S, Overbeek W, Heerdink E, Correll C, de Graeff E, Staal W
J Child Adolesc Psychopharmacol
. 2012 Apr;
22(2):166-73.
PMID: 22506734
Objective: Weight gain and metabolic adverse effects of second-generation antipsychotics (SGAs) have become a major concern, particularly in youth. However, the specific contribution of SGAs versus other medications or the...